Invokana Lawsuit: Have You Been Diagnosed With Kidney Failure? Have You Been Hospitalized With Ketoacidosis? You May Be Entitled To Compensation.
CALL TODAY: (888) 973-6379

Blog

Invokana Lawsuits Centralized in New Jersey MDL

Fifty-five lawsuits against Janssen Pharmaceuticals and its type 2 diabetes drug Invokana have been transferred and centralized before New Jersey District Court Judge Brian Martinotti. The cases, all similarly alleging that the drugmaker failed to adequately warn patients about the potential risks of kidney failure, diabetic ketoacidosis and heart attacks associated with Invokana, were corralled …. Read More

Invokana Class Action Lawsuit Filed in Canada

As individual lawsuits continue to be filed in the U.S., makers of Invokana face a class action lawsuit in Canada over a potentially fatal risk of kidney failure associated with the diabetes drug. Seeking an Invokana recall throughout the country, the class is alleging that Johnson & Johnson’s subsidiary Janssen Pharmaceuticals failed to provide adequate …. Read More

Comments Off on Invokana Class Action Lawsuit Filed in Canada

Report: Diabetic Ketoacidosis Predictable Among Invokana Patients

A report published by the American Diabetes Association in its journal Diabetes Care discusses some key information for Invokana users and their doctors. In light of the FDA’s May 2015 concerns that Invokana may carry an increased risk of diabetic ketoacidosis (DKA), or high levels of acid in the blood, researchers from the Dallas Diabetes and Endocrine …. Read More

Comments Off on Report: Diabetic Ketoacidosis Predictable Among Invokana Patients

FDA Ramps Up Invokana Warning Label

Diabetes drug Invokana recently received an updated warning label mandated by the FDA, to include stronger information about bone mineral density issues, including an increased risk for bone fractures as well as an “Adverse Reactions” section highlighting the drug’s risks. Invokana, a popular medication used to help lower blood sugar in type-2 diabetes patients, has been …. Read More

Comments Off on FDA Ramps Up Invokana Warning Label

Consumer Watchdog Group is On to Invokana’s Off-Label Marketing

In just 2.5 short years, newcomer Type-2 diabetes drug Invokana has rocketed to the top of the sales market, largely driven by advertisements directed at consumers. These advertisements, however, have raised concerns over how they affect the public’s perception of the safety and efficacy of the drug—often downplaying serious, life-threatening side effects.  Public Citizen, a …. Read More

Comments Off on Consumer Watchdog Group is On to Invokana’s Off-Label Marketing
Contact Us
Web Analytics